<?xml version="1.0" encoding="UTF-8"?>
<p>More recently, some authors have reported the usefulness of hydroxychloroquine at a dosage of 400 mg per day for ten days in the treatment of symptomatic SARS-CoV-2 pneumonia [
 <xref rid="B15-jcm-09-01138" ref-type="bibr">15</xref>]. The mechanism of action of these antimalarial drugs would result in an increase in endosomal pH by preventing the fusion between virus and cell, or interfering in the glycosylation process of cellular receptors of coronavirus. In addition, it is hypothesized that these antimalarials have an immunomodulating effect that contributes to increasing their efficacy in vivo [
 <xref rid="B16-jcm-09-01138" ref-type="bibr">16</xref>]. 
</p>
